# OnCo record scalop-2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/scalop-2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "scalop-2", "NCT02024009" ;
  schema:name "SCALOP-2"@en ;
  schema:alternateName "SCALOP 2"@en ;
  schema:description "SCALOP-2 is the UK follow-on to SCALOP, testing whether a higher radiotherapy dose or the HIV drug nelfinavir improves chemoradiotherapy for pancreatic cancer that cannot be removed; it finished in 2021 and its main results had not appeared in an indexed journal by September 2026."@en ;
  schema:url <https://onco.cc/trials/scalop-2/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02024009>, <https://www.isrctn.com/ISRCTN50083238> ;
  onco:status "completed" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/locally-advanced-pdac/> ;
  onco:technologies <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> ;
  onco:institutions <https://onco.cc/institutions/cruk/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/pancreatic-trials-open-today/> ;
  onco:trials <https://onco.cc/trials/scalop/> .